Targeting stim and Orai proteins as an alternative approach in anticancer therapy

Francesco Moccia, Estella Zuccolo, Valentina Poletto, Ilaria Turin, Germano Guerra, Paolo Pedrazzoli, Vittorio Rosti, Camillo Porta, Daniela Montagna

Research output: Contribution to journalReview article

Abstract

An increase in intracellular Ca2+ concentration plays a key role in the establishment of many cancer hallmarks, including aberrant proliferation, migration, invasion, resistance to apoptosis and angiogenesis. The dysregulation of Ca2+ entry is one of the most subtle mechanisms by which cancer cells overwhelm their normal counterparts and gain the adaptive advantages that result in tumour growth, vascularisation and dissemination throughout the organism. Both constitutive and agonist-induced Ca2+ influx may be mediated by store-dependent as well as store-independent Ca2+ entry routes. A growing body of evidences have shown that different isoforms of Stromal Interaction Molecules (Stim1) and Orai proteins, i.e. Stim1, Stim2, Orai1 and Orai3, underlie both pathways in cancer cells. The alteration in either the expression or the activity of Stim and Orai proteins has been linked to the onset and maintenance of tumour phenotype in many solid malignancies, including prostate, breast, kidney, esophageal, skin, brain, colorectal, lung and liver cancers. Herein, we survey the existing data in support of Stim and Orai involvement in tumourigenesis and provide the rationale to target them in cancer patients. Besides, we summarize the most recent advances in the identification of novel pharmacological tools that could be successfully used in clinical therapy.

Original languageEnglish
Pages (from-to)3450-3480
Number of pages31
JournalCurrent Medicinal Chemistry
Volume23
Issue number30
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Tumors
Cells
Liver
Brain
Neoplasms
Skin
Protein Isoforms
Proteins
Apoptosis
Molecules
Therapeutics
Kidney Neoplasms
Skin Neoplasms
Liver Neoplasms
Esophageal Neoplasms
Brain Neoplasms
Colorectal Neoplasms
Lung Neoplasms
Prostatic Neoplasms
Maintenance

Keywords

  • Angiogenesis
  • Apoptosis
  • Ca release-activated Ca current
  • Cancer
  • Metastasis
  • Orai
  • Proliferation
  • Stim
  • Store-operated Ca entry

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Targeting stim and Orai proteins as an alternative approach in anticancer therapy. / Moccia, Francesco; Zuccolo, Estella; Poletto, Valentina; Turin, Ilaria; Guerra, Germano; Pedrazzoli, Paolo; Rosti, Vittorio; Porta, Camillo; Montagna, Daniela.

In: Current Medicinal Chemistry, Vol. 23, No. 30, 01.09.2016, p. 3450-3480.

Research output: Contribution to journalReview article

Moccia, Francesco ; Zuccolo, Estella ; Poletto, Valentina ; Turin, Ilaria ; Guerra, Germano ; Pedrazzoli, Paolo ; Rosti, Vittorio ; Porta, Camillo ; Montagna, Daniela. / Targeting stim and Orai proteins as an alternative approach in anticancer therapy. In: Current Medicinal Chemistry. 2016 ; Vol. 23, No. 30. pp. 3450-3480.
@article{a3fc7a99dd3b44669b3e0f96c811f854,
title = "Targeting stim and Orai proteins as an alternative approach in anticancer therapy",
abstract = "An increase in intracellular Ca2+ concentration plays a key role in the establishment of many cancer hallmarks, including aberrant proliferation, migration, invasion, resistance to apoptosis and angiogenesis. The dysregulation of Ca2+ entry is one of the most subtle mechanisms by which cancer cells overwhelm their normal counterparts and gain the adaptive advantages that result in tumour growth, vascularisation and dissemination throughout the organism. Both constitutive and agonist-induced Ca2+ influx may be mediated by store-dependent as well as store-independent Ca2+ entry routes. A growing body of evidences have shown that different isoforms of Stromal Interaction Molecules (Stim1) and Orai proteins, i.e. Stim1, Stim2, Orai1 and Orai3, underlie both pathways in cancer cells. The alteration in either the expression or the activity of Stim and Orai proteins has been linked to the onset and maintenance of tumour phenotype in many solid malignancies, including prostate, breast, kidney, esophageal, skin, brain, colorectal, lung and liver cancers. Herein, we survey the existing data in support of Stim and Orai involvement in tumourigenesis and provide the rationale to target them in cancer patients. Besides, we summarize the most recent advances in the identification of novel pharmacological tools that could be successfully used in clinical therapy.",
keywords = "Angiogenesis, Apoptosis, Ca release-activated Ca current, Cancer, Metastasis, Orai, Proliferation, Stim, Store-operated Ca entry",
author = "Francesco Moccia and Estella Zuccolo and Valentina Poletto and Ilaria Turin and Germano Guerra and Paolo Pedrazzoli and Vittorio Rosti and Camillo Porta and Daniela Montagna",
year = "2016",
month = "9",
day = "1",
doi = "10.2174/0929867323666160607111220",
language = "English",
volume = "23",
pages = "3450--3480",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "30",

}

TY - JOUR

T1 - Targeting stim and Orai proteins as an alternative approach in anticancer therapy

AU - Moccia, Francesco

AU - Zuccolo, Estella

AU - Poletto, Valentina

AU - Turin, Ilaria

AU - Guerra, Germano

AU - Pedrazzoli, Paolo

AU - Rosti, Vittorio

AU - Porta, Camillo

AU - Montagna, Daniela

PY - 2016/9/1

Y1 - 2016/9/1

N2 - An increase in intracellular Ca2+ concentration plays a key role in the establishment of many cancer hallmarks, including aberrant proliferation, migration, invasion, resistance to apoptosis and angiogenesis. The dysregulation of Ca2+ entry is one of the most subtle mechanisms by which cancer cells overwhelm their normal counterparts and gain the adaptive advantages that result in tumour growth, vascularisation and dissemination throughout the organism. Both constitutive and agonist-induced Ca2+ influx may be mediated by store-dependent as well as store-independent Ca2+ entry routes. A growing body of evidences have shown that different isoforms of Stromal Interaction Molecules (Stim1) and Orai proteins, i.e. Stim1, Stim2, Orai1 and Orai3, underlie both pathways in cancer cells. The alteration in either the expression or the activity of Stim and Orai proteins has been linked to the onset and maintenance of tumour phenotype in many solid malignancies, including prostate, breast, kidney, esophageal, skin, brain, colorectal, lung and liver cancers. Herein, we survey the existing data in support of Stim and Orai involvement in tumourigenesis and provide the rationale to target them in cancer patients. Besides, we summarize the most recent advances in the identification of novel pharmacological tools that could be successfully used in clinical therapy.

AB - An increase in intracellular Ca2+ concentration plays a key role in the establishment of many cancer hallmarks, including aberrant proliferation, migration, invasion, resistance to apoptosis and angiogenesis. The dysregulation of Ca2+ entry is one of the most subtle mechanisms by which cancer cells overwhelm their normal counterparts and gain the adaptive advantages that result in tumour growth, vascularisation and dissemination throughout the organism. Both constitutive and agonist-induced Ca2+ influx may be mediated by store-dependent as well as store-independent Ca2+ entry routes. A growing body of evidences have shown that different isoforms of Stromal Interaction Molecules (Stim1) and Orai proteins, i.e. Stim1, Stim2, Orai1 and Orai3, underlie both pathways in cancer cells. The alteration in either the expression or the activity of Stim and Orai proteins has been linked to the onset and maintenance of tumour phenotype in many solid malignancies, including prostate, breast, kidney, esophageal, skin, brain, colorectal, lung and liver cancers. Herein, we survey the existing data in support of Stim and Orai involvement in tumourigenesis and provide the rationale to target them in cancer patients. Besides, we summarize the most recent advances in the identification of novel pharmacological tools that could be successfully used in clinical therapy.

KW - Angiogenesis

KW - Apoptosis

KW - Ca release-activated Ca current

KW - Cancer

KW - Metastasis

KW - Orai

KW - Proliferation

KW - Stim

KW - Store-operated Ca entry

UR - http://www.scopus.com/inward/record.url?scp=84996522042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996522042&partnerID=8YFLogxK

U2 - 10.2174/0929867323666160607111220

DO - 10.2174/0929867323666160607111220

M3 - Review article

AN - SCOPUS:84996522042

VL - 23

SP - 3450

EP - 3480

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 30

ER -